>
Organization
Sarepta Therapeutics, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Sarepta Therapeutics, Inc.

... Sarepta Therapeutics said the Food and Drug Administration wanted the company to conduct ...
... CAMBRIDGE, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a leader in precision genetic medicine for rare diseases, today ...
... CAMBRIDGE, Mass., Dec. 31, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a leader in precision genetic medicine for rare diseases, granted ...
... that target RNA splicing. When Dr. Ed Kaye was chief executive of Sarepta Therapeutics, he steered the Cambridge company through the controversial approval of its ...
... RNA-based platform -- CAMBRIDGE, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a leader in precision genetic medicine for rare diseases, announced ...
... Ruff, previously Chief Regulatory Affairs Officer and SVP, Head of Quality at Sarepta Therapeutics, joins as Senior Vice President of Regulatory Affairs and Quality. Nancy ...
... sales at Insmed Inc. since 2017. Previously, Mr. Hoitt held roles at Sarepta Therapeutics from 2013 to 2017, including Head of U.S. Sales and Senior ...
... CAMBRIDGE, Mass., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, announced ...
... periods relates primarily to the Group's licence and collaboration agreement with Sarepta Therapeutics, Inc. (-Sarepta'). The increase in revenues during the nine months ended 31 ...
Subscribe now for full coverage on Sarepta Therapeutics, Inc.
Start My Free Trial